Neurotransmitter transporters: Target for endocrine regulation

Hormone and Metabolic Research

Volumn 31, Issue 5, 1999, Pages 335-339

  Figlewicz, D P ^a,b   Patterson, T A ^c   Zavosh, A ^a   Brot, M D ^a   Roitman, M ^a   Szot, P ^a,b   Lattemann, Dianne Figlewicz ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Aldosterone; Dopamine; Estrogen; Glucocorticoids; Insulin; Transporters

Indexed keywords

ALDOSTERONE; DOPAMINE; GLUCOCORTICOID; INSULIN;

ALDOSTERONE RELEASE; ANIMAL CELL; CONFERENCE PAPER; DOPAMINE RELEASE; HORMONAL REGULATION; HORMONE RELEASE; INSULIN RELEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032993394     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978749     Document Type: Conference Paper

References (58)

1. 1. Shimada S, Kitayama S, Lin C-L, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 1991; 254: 576-8
2. 2. Kilty JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991; 254: 578-9
3. 3. Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, Davidson N, Lester HA, Kanner BI. Cloning and expression of a rat brain GABA transporter. Science 1990; 249: 1303-6
4. 4. Hoffman BJ. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs. Pharmacopsychiatr 1994; 27: 16-22
5. 5. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 1991; 350: 350-4
6. 6. Szot P, Ashliegh EA, Kohen R, Petrie E, Dorsa DM, Veith R. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short-and long-term desipramine treatment. Brain Res 1993; 618: 308-12
7. 7. Shores MM, Szot P, Veith RC. Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via alpha 2 receptors. Brain Res Mol Brain Res 1994; 27: 337-41
8. 8. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 1992; 89: 7782-5
9. 9. Meiergerd SM, Hooks SM, Schenk JO. The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration. J Neurochem 1994; 63: 1277-81
10. 10. Povlock SL, Amara SG. The structure and function of norepinephrine, dopamine and serotonin transporters. In Reith MEA (ed) Neurotransmitter Transporters Totowa NJ Humana 1997: pp 1-28
11. 11. Kitayama S, Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jap J Pharm 1996; 72: 195-208
12. 12. Corey JL, Davidson N, Lester HA, Brecha N, Quick MW. Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem 1994; 269: 14759-67
13. max. J Neurochem 1997; 68: 225-232
14. 14. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 1997; 17: 45-57
15. 15. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 1998; 273: 2458-66
16. 16. Vaughan RA, Uhl GR. Protein kinase C stimulates dopamine transporter serine phosphorylation. Soc Neurosci Abstr 1998; 23: 1131
17. 17. Quick MW, Corey JL, Davidson N, Lester HA. Second messengers, trafficking-related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J Neurosci 1997; 17: 2967-79
18. 18. Li u F, McConkey F, Man HY, Lee FJS, Levey AI, Wang YT, Pristupa ZB, Niznik HB. Second messenger mediated translocation of the human dopamine transporter. Soc Neurosci Abstr 1997; 23: 692
19. 19. Vrindavanam NS, Arnaud P, Ma JX, Altman-Hamamdzic S, Parratto NP, Sallee FR. The effects of phosporylation on the functional regulation of an expressed recombinant human dopamine transporter. Neurosci Lett 1996; 216: 133-6
20. 20. Copeland BJ, Vogelsberg V, Neff NH, Hadjiconstantinou M. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J Pharm Exp Ther 1996; 277: 1527-32
21. 21. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 1980; 255: 4758-62
22. 22. Boyd FT Jr, Clarke DW, Raizada MK. Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain. Brain Res 1986; 398: 1-5
23. 23. Boyd FT Jr, Clarke DW, Muther TF, Raizada MK. Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain. J Biol Chem 1985; 260: 15880-4
24. 24. Figlewicz DP, Bentson K, Ocrant I. The effect of insulin on norepinephrine uptake by PC-12 cells. Brain Res Bull 1993; 32: 425-31
25. 25. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endo Rev 1995: 117-42
26. 26. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res 1993; 602: 161-4
27. 27. Figlewicz DP, Szot P, Chavez M, Woods SC, Veith RC. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/ substantia nigra. Brain Res 1994; 644: 331-4
28. 28. Tian Y, Kapatos G, Granneman JC, Bannon MJ. Dopamine and γ-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation. Neurosci Lett 1994; 173: 143-6
29. 29. Attali G, Weizman A, Gil-Ad I, Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res 1997; 756: 153-9
30. 30. Figlewicz DP, Brot MD, McCall AL, Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res 1996; 736: 54-60
31. 31. Patterson T, Brot MD, Zavosh A, Schenk JO, Szot P, Figlewicz DP. Fasting decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 1998; 68: 11-20
32. 32. Simon JR, Bare DJ, Ghetti B, Richter JA. A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum. Neurosci Lett 1997; 224: 201-5
33. A receptors to postsynaptic domains by insulin. Nature 1997; 388: 686-90
34. 34. Fleckenstein AE, Pogun S, Carroll FI, Kuhar MJ. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 B-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenyethyl ester hydrochloride]. J Pharm Exp Ther 1996; 279: 200-6
35. 35. Zhou D, Huether G, Wiltfang J, Hajak G, Ruther E, Serotonin transporters in the rat frontal cortex: lack of circadian rhythmicity but down-regulation by food restriction. J Neurochem 1996
36. 36. Patterson TA, Zavosh A, Schenk JO, Wilkinson CW, Figlewicz DP. Corticosterone decreases dopamine transporter activity in rat nucleus accumbens in vitro. Soc Neurosci Abstr 1997; 23: 693
37. 37. Brann DW, Hendry LB, Mahesh VB. Emerging diversities in the mechanism of action of steroid hormones. J Steroid Biochem Mol Biol 1995; 52: 113-33
38. 38. Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science 1991; 252: 1848-51
39. 39. Gilad GM, Rabey JM, Gilad VH. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci 1987; 40: 2401-8
40. 40. Roitman MF, Patterson TA, Bernstein IL, Figlewicz Lattemann D. Induction of sodium appetite decreases dopamine (DA) reuptake in the nucleus accumbens (Nacc) but not the striatum (Str) in rats. Soc Neurosci Abstr 1997; 23: 1359
41. 41. Thompson TL, Moss RL. Estrogen regulation of dopamine release in the nucleus accumbens: Genomic-and nongenomic-mediated effects. J Neurochem 1994; 62: 1750-6
42. 42. Fumagalli F, Jones SR, Caron MG, Seidler FJ, Slotkin TA. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res 1996; 719: 225-8
43. 43. Bosse R, Rivest R, Di Paolo T. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Mol Brain Res 1997; 46: 343-6
44. 44. Yang SP, Pau KY, Spies HG. Gonadectomy alters tyrosine hydroxylase and norepinephrine transporter mRNA levels in the locus coeruleus in rabbits. J Neuroendocrinol 1997; 9: 763-8
45. 45. Tejani-Butt SM, Yang J. A time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography, Neuroendocrinology 1994; 59: 235-44
46. 46. Giros G, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-12
47. 47. Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disorders 1997; 12: 629-33
48. 48. Silvia CP, Jaber M, King GR, Ellinwood EH, Caron MG. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 1997; 76: 737-47
49. 49. Piazza PV, Le Moal ML. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Ann Rev Pharm Tox 1996; 36: 359-78
50. 50. Piazza PV, Rouge-Pont F, Deroche V, Maccari S, Simon H, Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 1996; 93: 8716-20
51. 51. Sorg BA, Kalivas PW. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res 1991; 559: 29-36
52. 52. Shaham Y, Stewart J. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology 1994; 114: 523-7
53. 53. Bell SM, Steward RB, Thompson SC, Meisch RA. Food-deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacol 1997; 131: 1-8
54. 54. Carroll ME, Meisch RA. Increased drug-reinforced behavior due to food deprivation. In Thompson T, Dews PB, Barrett JE (eds) Advances in Behavioral Pharmacology New York Academic Press 1984: pp 47-88
55. 55. Sakai RR, Nicolaidis S, Epstein AN. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol 1986; 251: R762-8
56. 56. Roitman MF, Schafe GE, Thiele TE, Bernstein IL. Dopamine and sodium appetite: antagonists suppress sham drinking of NaCI solutions in the rat. Behav Neurosci 1997; 111: 606-11
57. 57. Bloom FE, Kupfer DJ, eds in chief:. Psychopharmacology: The Fourth Generation of Progress. New York Raven Press Ltd 1995
58. 58. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997; 154: 1641-7